Get the Stockscreener App
0.3935
14.68%
-0.0677
After Hours:
.39
-0.0035
-0.89%
Profusa Inc stock is traded at $0.3935, with a volume of 7.84M.
It is down -14.68% in the last 24 hours and down -19.69% over the past month.
Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
See More
Previous Close:
$0.4612
Open:
$0.4198
24h Volume:
7.84M
Relative Volume:
0.90
Market Cap:
$12.90M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+28.43%
1M Performance:
-19.69%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.36
$0.4556
1-Week Range:
$0.265
$0.60
52-Week Range:
$0.265
$2.22
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3935 | 9.56M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Profusa Inc Stock (PFSA) Latest News
Profusa (PFSA) Stock: Soars 76% on NVIDIA-Powered AI Breakthrough in Biochemistry Monitoring - parameter.io
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring - GlobeNewswire
Profusa’s Risky Vision for High-Tech Medical Sensors - Finimize
Profusa Approves $100 Million Equity Line of Credit - MSN
Profusa shareholders approve $100 million equity line of credit with Ascent Partners By Investing.com - Investing.com South Africa
Profusa shareholders approve $100 million equity line of credit with Ascent Partners - Investing.com Australia
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base - GlobeNewswire
300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital - Stock Titan
Profusa's Strategic Position in Digital Health Innovation - AInvest
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan
Profusa announces commercial and clinical collaboration with head of angiography, Medical University of Graz, Austria - MarketScreener
Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire
Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan
Profusa amends purchase agreement and note terms for convertible debt tranches - Investing.com Australia
Profusa Restructures Securities Agreement for Enhanced Flexibility - AInvest
Profusa Restructures Securities Agreement for Flexibility - MSN
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Profusa Appoints New CFO and Lead Director - TipRanks
Profusa, Inc. shares fall 8.88% intraday despite adding seasoned finance executive Fred Knechtel as CFO. - AInvest
Profusa adds former VA chief and Fortune 500 executive to leadership - Investing.com
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO - The Manila Times
Profusa Welcomes Former Acting U.S. Veterans Affairs - GlobeNewswire
Profusa, Inc. Appoints Fred Knechtel as CFO - MarketScreener
Profusa, Inc. shares rise 4.26% premarket after announcing a distributor for its tissue oxygen technology. - AInvest
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform - MarketScreener
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa, Inc. SEC 10-Q Report - TradingView
Profusa Announces Nasdaq Listing and Growth Plans - TipRanks
Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang - AlphaStreet
Profusa shares strategy update as it transitions to public company By Investing.com - Investing.com South Africa
Profusa shares strategy update as it transitions to public company - Investing.com India
Profusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing - Quiver Quantitative
Profusa Achieves Milestones, Commits to Groundbreaking Biochemistry Tech. - AInvest
Profusa, Inc. Provides Strategy Overview and Business Update for Investors - Bluefield Daily Telegraph
Profusa Reports Q1 2026 Commercial Launch in Europe for Tissue Oxygen Monitoring Platform - AInvest
Digital Health Pioneer Profusa Unveils $10B Market Strategy for Biochemistry Platform | PFSA Stock News - Stock Titan
Profusa, Inc. Secures Lumee?? Oxygen Platform Distributor in Spain - MarketScreener
Profusa signs LOI for distribution of Lumee Oxygen platform in Spain - Investing.com Australia
Profusa Secures Lumee™ Oxygen Platform Distributor in Spain - The Manila Times
Profusa Signs Letter of Intent for Lumee Oxygen Distribution in Spain. - AInvest
Profusa Targets 300,000 Annual European Procedures with Spanish Distribution Partnership - Stock Titan
Profusa Secures Lumee Oxygen Platform Distributor in Spain - 富途牛牛
Profusa Inc Stock (PFSA) Financials Data
There is no financial data for Profusa Inc (PFSA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):